Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001574436 | SCV001801255 | uncertain significance | not provided | 2022-10-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001574436 | SCV004624484 | benign | not provided | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004651692 | SCV005141524 | uncertain significance | Inborn genetic diseases | 2024-05-29 | criteria provided, single submitter | clinical testing | The c.2307T>G (p.H769Q) alteration is located in exon 20 (coding exon 19) of the NALCN gene. This alteration results from a T to G substitution at nucleotide position 2307, causing the histidine (H) at amino acid position 769 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome |
RCV001825005 | SCV002075026 | not provided | Hypotonia, infantile, with psychomotor retardation and characteristic facies 1; Congenital contractures of the limbs and face, hypotonia, and developmental delay | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 02-05-2020 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |